LeukoStrat K4120361

GUDID 00850052003739

The LeukoStrat CDx FLT3 Mutation Assay is a PCR-based in vitro diagnostic test designed to detect internal tandem duplication (ITD) and tyrosine kinase domain (TKD) mutations D835 and I836 in the FLT3 gene in genomic DNA extracted from mononuclear cells obtained from peripheral blood or bone marrow aspirates of patients diagnosed with acute myelogenous leukemia (AML).

INVIVOSCRIBE, INC.

Acute myeloid leukaemia (AML) genetic mutation IVD, kit, nucleic acid technique (NAT) Acute myeloid leukaemia (AML) genetic mutation IVD, kit, nucleic acid technique (NAT) Acute myeloid leukaemia (AML) genetic mutation IVD, kit, nucleic acid technique (NAT) Acute myeloid leukaemia (AML) genetic mutation IVD, kit, nucleic acid technique (NAT) Acute myeloid leukaemia (AML) genetic mutation IVD, kit, nucleic acid technique (NAT) Acute myeloid leukaemia (AML) genetic mutation IVD, kit, nucleic acid technique (NAT) Acute myeloid leukaemia (AML) genetic mutation IVD, kit, nucleic acid technique (NAT) Acute myeloid leukaemia (AML) genetic mutation IVD, kit, nucleic acid technique (NAT) Acute myeloid leukaemia (AML) genetic mutation IVD, kit, nucleic acid technique (NAT) Acute myeloid leukaemia (AML) genetic mutation IVD, kit, nucleic acid technique (NAT) Acute myeloid leukaemia (AML) genetic mutation IVD, kit, nucleic acid technique (NAT) Acute myeloid leukaemia (AML) genetic mutation IVD, kit, nucleic acid technique (NAT) Acute myeloid leukaemia (AML) genetic mutation IVD, kit, nucleic acid technique (NAT) Acute myeloid leukaemia (AML) genetic mutation IVD, kit, nucleic acid technique (NAT) Acute myeloid leukaemia (AML) genetic mutation IVD, kit, nucleic acid technique (NAT) Acute myeloid leukaemia (AML) genetic mutation IVD, kit, nucleic acid technique (NAT) Acute myeloid leukaemia (AML) genetic mutation IVD, kit, nucleic acid technique (NAT) Acute myeloid leukaemia (AML) genetic mutation IVD, kit, nucleic acid technique (NAT) Acute myeloid leukaemia (AML) genetic mutation IVD, kit, nucleic acid technique (NAT) Acute myeloid leukaemia (AML) genetic mutation IVD, kit, nucleic acid technique (NAT) Acute myeloid leukaemia (AML) genetic mutation IVD, kit, nucleic acid technique (NAT) Acute myeloid leukaemia (AML) genetic mutation IVD, kit, nucleic acid technique (NAT) Acute myeloid leukaemia (AML) genetic mutation IVD, kit, nucleic acid technique (NAT) Acute myeloid leukaemia (AML) genetic mutation IVD, kit, nucleic acid technique (NAT) Acute myeloid leukaemia (AML) genetic mutation IVD, kit, nucleic acid technique (NAT) Acute myeloid leukaemia (AML) genetic mutation IVD, kit, nucleic acid technique (NAT) Acute myeloid leukaemia (AML) genetic mutation IVD, kit, nucleic acid technique (NAT) Acute myeloid leukaemia (AML) genetic mutation IVD, kit, nucleic acid technique (NAT) Acute myeloid leukaemia (AML) genetic mutation IVD, kit, nucleic acid technique (NAT) Acute myeloid leukaemia (AML) genetic mutation IVD, kit, nucleic acid technique (NAT) Acute myeloid leukaemia (AML) genetic mutation IVD, kit, nucleic acid technique (NAT)
Primary Device ID00850052003739
NIH Device Record Key315f621c-c089-4b54-9b0d-97ab9215ab5c
Commercial Distribution StatusIn Commercial Distribution
Brand NameLeukoStrat
Version Model Number850052003739
Catalog NumberK4120361
Company DUNS836976779
Company NameINVIVOSCRIBE, INC.
Device Count1
DM Exempttrue
Pre-market Exemptfalse
MRI Safety StatusLabeling does not contain MRI Safety Information
Human Cell/Tissue Productfalse
Device Kittrue
Device Combination Productfalse
Single Usefalse
Lot Batchtrue
Serial Numberfalse
Manufacturing Datefalse
Expiration Datetrue
Donation Id Numberfalse
Contains Natural Rubber Latexfalse
Labeled No Natural Rubber Latexfalse
RX Perscriptiontrue
OTC Over-The-Counterfalse

Device Identifiers

Device Issuing AgencyDevice ID
GS100850052003739 [Primary]

FDA Pre-market Approvals/Notifications & deNovo

FDA Product Code

OWDSomatic Gene Mutation Detection System

Sterilization

Steralize Prior To Usefalse
Device Is Sterilefalse

Device Entry Metadata

Public Version StatusUpdate
Device Record StatusPublished
Public Version Number2
Public Version Date2021-01-19
Device Publish Date2020-06-08

On-Brand Devices [LeukoStrat]

00850052003685The LeukoStrat CDx FLT3 Mutation Assay targets regions of the FLT3 gene to identify internal tan
00850052003739The LeukoStrat CDx FLT3 Mutation Assay is a PCR-based in vitro diagnostic test designed to detec
00810022732571The LeukoStrat CDx FLT3 Mutation Assay is a PCR-based in vitro diagnostic test designed to detec

Trademark Results [LeukoStrat]

Mark Image

Registration | Serial
Company
Trademark
Application Date
LEUKOSTRAT
LEUKOSTRAT
86560545 5628108 Live/Registered
INVIVOSCRIBE, INC.
2015-03-11
LEUKOSTRAT
LEUKOSTRAT
76693161 not registered Dead/Abandoned
InVivoScribe Technologies LLC
2008-09-29

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.